MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results
Portfolio Pulse from
MiMedx Group, Inc. reported a 7% increase in net sales for Q4 and a 9% increase for the full year 2024. The company achieved a GAAP net income of $7 million and an EPS of $0.05 for Q4. Adjusted EBITDA was $20 million, representing 21% of net sales.
February 26, 2025 | 9:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MiMedx Group reported a 7% increase in Q4 net sales and a 9% increase for the full year 2024. The company achieved a GAAP net income of $7 million and an EPS of $0.05 for Q4. Adjusted EBITDA was $20 million, representing 21% of net sales.
The positive financial results, including increased net sales and profitability metrics, are likely to boost investor confidence and positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100